✦ LIBER ✦

Phase I study of docetaxel in combination with gemcitabine as first line chemotherapy (CT) in patients with metastatic non-small cell lung cancer (NSCLC)

✍ Scribed by Bildat, S.; Gatzemeier, U.; Reck, M.; Harstrick, A.; Eberhardt, W.; Achterrath, W.; Krauss, C.; Wilke, H.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase II study with two gemci

✍ Alessandro Passardi; Lorenzo Cecconetto; Monia Dall'Agata; Claudio Dazzi; Enzo P 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 197 KB

P0021 Gemcitabine–docetaxel versus cispl

✍ Al-Gizawy, S.M.; Mostafa, H.G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Gemcitabine plus docetaxel as first-line

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB

209 Phase I study of docetaxel (D) (Taxo

✍ Manegold, Chr.; Buchholz, E.; Schwalb, M.; Achterrath, W.; Drings, P. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 155 KB

A phase I–II study of docetaxel (D) and

✍ Quantin, X; Rebattu, P; Pujol, J; Morere, J; Azarian, M.R; Khial, F; Dumortier, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

9149 Phase II study of bevacizumab in co

✍ Ferrer, N.; Cobo, M.; Paredes, A.; Méndez, M.; Muñoz-Langa, J.; Rueda, A.; de Mo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB